Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Reveal soon? Or perhaps a longer wait?…regardless nice run

<< Previous

Bullboard Posts

Next >>

Post by canadafanon Aug 08, 2022 6:00pm

326 Views

Post# 34880092

Reveal soon? Or perhaps a longer wait?…regardless nice run

Those who were brave & smart enough to buy in/ more when things were looking dark...AKA, sub $1.00 on NASdaq , are looking good on that $$$.
key is to look beyond the SP , and realize to potential upside.
So far, we have predictions from $6ps ( RBC analyst), $15 PS USA analysts, to potential $20- $60- $200ps.
potentail takeover prices etc etc.
there are many substatiating comparables to justify any of the numbers ( the RBC is very low & not indicating a buy out, only includes potential income from one cancer use).
regardless of which you pick, the upside is huge.
downside?
There has been nothing but good news last 6 months.
any downticks would be very short lived.